Epcoritamab and Rituximab for First-line Follicular Lymphoma
Clinical trial NCT05783609 · RECRUITING
Trial details
- NCT number
- NCT05783609
- Sponsor
- Reid Merryman, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2028-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.